REG - Inspiration Health - Capital Markets Day

Inspiration HealthcareAnnouncement

13/07/2022 07:01

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220713:nRSM2374Sa&default-theme=true

RNS Number : 2374S  Inspiration Healthcare Group PLC  13 July 2022

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

 

 

 Capital Markets Day

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology
company, is hosting a Capital Markets Day for institutional investors today at
its new manufacturing and technology centre in Croydon which is the main
centre for R&D and Manufacturing of capital equipment, including  the SLE
brand of ventilators. The event is being hosted by Chief Executive Officer
Neil Campbell and Chief Financial Officer Jon Ballard and will provide a
deeper understanding of the Group's strategy and the actions which are driving
profitable growth. A further event, for private investors is being planned for
later in the year.

The Group remains in line with meeting the board's expectations for FY22/23.
Please note that no further material new information with regards to FY22/23
trading and outlook will be shared during the presentations.

The presentation slides will be available via the Company's
website:www.inspirationhealthcaregroup.plc.uk
(http://www.inspirationhealthcaregroup.plc.uk)

 

Enquiries:

 

 Inspiration Healthcare Group plc                                                                                                                                                       Tel: 0330 175 0000

 Neil Campbell, Chief Executive Officer

 Jon Ballard, Chief Financial Officer
 Nominated Adviser & Broker                                                                                                                                                             Tel: 0207 397 8900

 Cenkos Securities plc

 Mark Connelly

 Stephen Keys

 Katy Birkin
 Cadogan                                                                                                                                                                                Tel: 07771 713608
 PR

 Alex Walters

 alex.walters@cadoganpr.com (mailto:alex.walters@cadoganpr.com)

 

About Inspiration Healthcare Group

 

www.inspirationhealthcaregroup.plc.uk
(http://www.inspirationhealthcaregroup.plc.uk/)

 

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology
for use in critical care & operating theatres. The Company provides
high-quality, innovative products to patients around the world which help to
improve patient outcomes, and it actively invests in innovative product
opportunities and disruptive technologies.

 

The Group currently consists of three companies: Inspiration Healthcare Ltd,
SLE Ltd and Viomedex Ltd and under these brands the Group sells neonatal
intensive care and operating theatre equipment around the work through a
network of distributors into over 75 countries.  Products range from highly
sophisticated capital equipment through to single use disposables all that can
help improve outcomes of extremely sick patients.

 

In the UK and Ireland the Group offers direct sales for most of its products
supported by Technical Service offering on site and return to base repair and
maintenance along with 24/7 emergency hire of equipment and long term lease
arrangements for its own brand products.  The Group also acts as a
distributor for 3rd party companies that wish to access the NHS using the
Group's sales and service expertise and knowledge of the NHS

 

The Group invests in growth through Research and Development holding numerous
patents on its technology and has strong links with academic Key Opinion
Leaders around the world and supports clinical research in the field of
neonatal intensive care.

 

Further information on Inspiration Healthcare Group plc can be seen
at  www.inspirationhealthcaregroup.plc.uk
(http://www.inspirationhealthcaregroup.plc.uk/)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCZZGMNVZMGZZM